Menu

Interim CNRS President Removed, Faces Data Manipulation Allegations

Anne Peyroche has been acting president of the French science organization since last October.

Jan 23, 2018
Ashley Yeager

ISTOCK, DNY59Biologist Anne Peyroche is no longer interim president of the National Center for Scientific Research (CNRS), one of the largest research organizations in France. She was removed last Thursday (January 18) from the post. In recent months, concerns have emerged that figures in some of her papers have been manipulated, although it’s not clear whether those allegations are related to her replacement. Computer scientist Antoine Petit has taken her place, according to the French Ministry of Higher Education, Research, and Innovation.

Evidence of possible data manipulation in Peyroche’s papers was first published last November on PubPeer, a website that lets users critique published research. Five articles that she coauthored between 2001 and 2012 are criticized on the site.  

Peyroche and her colleagues responded to two of the threads, but the criticisms were serious enough for a committee at the French Alternative Energies and Atomic Energy Commission (CEA) to seek more information from the researchers. A panel of reviewers was set up to hear clarifications from the papers’ coauthors in early January, Le Monde reports. That process was disrupted by the announcement of Petit succeeding Peyroche.

It’s not clear whether Peyroche’s replacement was premature. Benoît Le Tallec, first author of two of the papers in question, had prepared responses to the criticisms, which he believed would “end the controversy,” according to a Google translation of the Le Monde piece. His former manager, however, had not forwarded these to PubPeer.

Still, the misconduct evaluation committee remains at work, according to Le Monde, even as Petit steps in at the helm of CNRS.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!